3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Hypersensitivity, Type III in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koo, G; Qing, X; Redecha, P; Salmon, JE; Vukelic, M | 1 |
1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Hypersensitivity, Type III
Article | Year |
---|---|
Cholinergic receptors modulate immune complex-induced inflammation in vitro and in vivo.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Ascitic Fluid; Benzylidene Compounds; Cell Adhesion; Cells, Cultured; Chemokine CXCL1; Chemotaxis, Leukocyte; Complement C5a; Cytokines; Female; Humans; I-kappa B Kinase; Immune Complex Diseases; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Nicotine; Nicotinic Agonists; Phagocytes; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Reactive Oxygen Species; Receptor, Anaphylatoxin C5a; Receptors, IgG; Recombinant Proteins; Respiratory Burst; Specific Pathogen-Free Organisms | 2013 |